In another model of PTSD that involves single prolonged stress (SPS), FGF2 administration was shown to inhibit SPS-induced hyperarousal and anxiety behavior, symptoms resembling PTSD. This evidence concerns the gene FGF2 and post-traumatic stress disorder.